Business Wire

Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study

HAMPTON, England--(BUSINESS WIRE)--Touchlight, a CDMO enabling the development of genetic medicines with its enzymatic doggybone DNA (dbDNA) technology, today announced that the Company has used its ...
Business Wire

Touchlight Completes Expansion, Creating One of the World’s Largest DNA Manufacturing Facilities in London, UK

Touchlight’s proprietary doggybone DNA (dbDNA™) overcomes the technical challenges associated with efficiently mass-producing plasmid DNA. The patented dbDNA technology produces a minimal, linear, ...
GEN

doggybone DNA: A Rapid Enzymatic GMP Starting Material for mRNA Production

Many biotech and pharmaceutical companies focused on mRNA manufacturing experience challenges associated with their plasmid DNA (pDNA) supply, including slow or delayed production and poor or ...
FiercePharma

GSK inks deal with CDMO Touchlight for access to its ‘doggybone DNA’ tech

GSK and Touchlight signed a non-exclusive licensing deal that gives the pharma giant access to the CDMO’s manufacturing tech. (Getty Images) Pharma giant GSK inked a licensing deal with Touchlight, ...
streetinsider

Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study

Based on prior manufacturing agreement that encompasses usage of Touchlight’s doggybone DNA (dbDNA™) to manufacture clinical supply of VMB-100 for Phase 2a trial to treat stress urinary incontinence ...
markets.financialcontent

Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Based on prior manufacturing agreement that ...